Observing the outcomes of hospitalized patients with acute kidney injury in China
Prognosis of Acute Kidney Injury:China Collaborative Study on AKI（CCS-AKI）Study
This study looks at how hospitalized patients with acute kidney injury in China recover and whether they are at risk of developing long-term kidney problems or facing higher death rates.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 1000000 (estimated) |
| Sex | All |
| Sponsor | Guangdong Provincial People's Hospital Academic / other |
| Locations | 1 site (Guangzhou, Guangdong) |
| Trial ID | NCT03061786 on ClinicalTrials.gov |
What this trial studies
This observational study focuses on the prognosis of patients diagnosed with acute kidney injury (AKI) in hospitals across China. It aims to gather data on the outcomes of these patients, particularly regarding the risk of developing chronic kidney disease and the associated mortality rates. By adhering to the KDIGO criteria for AKI diagnosis, the study will analyze the clinical characteristics and progression of AKI in a real-world setting. The findings could provide valuable insights into the management and treatment of AKI in hospitalized patients.
Who should consider this trial
Good fit: Ideal candidates for this study are hospitalized patients who have been clinically diagnosed with acute kidney injury.
Not a fit: Patients who have undergone nephrectomy, kidney transplantation, or have end-stage kidney disease will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could enhance understanding of AKI prognosis and improve patient management strategies, potentially reducing long-term complications.
How similar studies have performed: Other studies have shown success in understanding AKI prognosis, but this specific observational approach in China may provide novel insights.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * clinically diagnosed with acute kidney injury, according to KDIGO criteria Exclusion Criteria: * Nephrectomy * Kidney transplantation * Peak serum creatinine of less than 53µ mol/L * Serum creatinine decrease after amputation * Patients died during hospitalization * End-stage kidney disease(chronic kidney disease stage 5) * malnutrition
Where this trial is running
Guangzhou, Guangdong
- Guangdong General Hospital — Guangzhou, Guangdong, China (Recruiting)
Study contacts
- Study coordinator: Liang Xinling, MD,PhD
- Email: xinlingliang@139.com
- Phone: 86-13808819770
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.